Results 221 to 230 of about 3,165,419 (303)

Blood Flow Restriction Training in Seniors: An Alternative to High-Load Resistance Training. [PDF]

J Clin Med
Kasicki K, Błażejewski G.
europepmc   +1 more source

Dynamic survival risk prediction with time‐varying high‐dimensional images

Canadian Journal of Statistics, EarlyView.
Abstract Integrating longitudinal data with survival models is a prevalent strategy for dynamic survival risk prediction while accounting for subjects' longitudinally observed variables. However, existing methods primarily focus on scalar longitudinal data and seldom tackle the complexities associated with high‐dimensional longitudinal imaging data ...
Bingfan Liu, Haolun Shi, Shu Jiang, Liangliang Wang, Da Ma, Mirza Faisal Beg, Jiguo Cao, for the Alzheimer's Disease Neuroimaging Initiative   +7 more
wiley   +1 more source

Recent Advances in Ultrasound-Guided Hydrodissection and Dextrose Prolotherapy for Musculoskeletal Pain: A Target-Based State-of-the-Art Narrative Review. [PDF]

Life (Basel)
Yoon Y, Park R, Shim J, Kim S, Lee J, Maniquis-Smigel L, Lam KHS, Suryadi T, Suhaimi A.   +8 more
europepmc   +1 more source

Risk of Bias Associated with Varying Sampling Strategies for External Comparator Cohorts for Single‐Arm Trials: Insights from Aggressive Lymphoma

Clinical Pharmacology &Therapeutics, EarlyView.
Marketing authorizations for oncology drugs are often based on single‐arm trials (SATs), and real‐world data‐based external comparator cohorts (ECCs) are increasingly explored to contextualize results. In retrospective studies, comparators may be identified by time of diagnosis but included based on time of relapse; such sampling strategies can ...
Mikkel Runason Simonsen, Shiva Leisner, Ahmed Ludvigsen Al‐Mashhadi, Laurids Østergaard Poulsen, Matthew Maurer, Lasse Hjort Jakobsen, Tarec Christoffer El‐Galaly   +6 more
wiley   +1 more source

Engineering the Biological Identity of Poly(lactic-co-glycolic Acid) Nanocarriers: Protein-Corona Dynamics, Functional Reprogramming, and Translational Fate. [PDF]

Curr Issues Mol Biol
Omidian H, Kianinejad N, Cubeddu LX.
europepmc   +1 more source

Toward Fit‐for‐Purpose Data for Drug Assessment in Non‐small Cell Lung Cancer: A Core Dataset

Clinical Pharmacology &Therapeutics, EarlyView.
Considering the high unmet medical need in people with non‐small cell lung cancer (NSCLC), the drug assessment for targeted therapies often rely on small populations and single‐arm trials, challenging the evaluation by regulatory authorities, health technology assessment bodies (HTAb), and clinicians.
Geeske F. Grit, Maaike van Dartel, Laura Rodwell, Hanneke van der Woude, Cornelis Boersma, Peter G. M. Mol, Doranne Hilarius   +6 more
wiley   +1 more source

A 2-GS/s 35.9-fJ/conv.-step Voltage-Time Hybrid Pipelined ADC with Digital Background Calibration in 28-nm CMOS. [PDF]

Micromachines (Basel)
Chang Y, Zhang C, Yang Y, Zhang C, Liu M, Chen D, Yang Y.   +6 more
europepmc   +1 more source

Considerations for the Integration of Clinical Trials and Real‐World Data

Clinical Pharmacology &Therapeutics, EarlyView.
As clinical decision‐making increasingly moves toward individualized and context‐specific treatment recommendations, reliance on any single evidence source, randomized or observational, may be insufficient. Principled integration of randomized controlled trials and real‐world data, grounded in explicit causal frameworks, offers a path toward evidence ...
Sky Qiu, Charles E. Barr, Lauren Dang, Larry Han, Kajsa Kvist, Hana Lee, Andrew Mertens, Nerissa Nance, Lei Nie, Kara Rudolph, Xu Shi, Jens Tarp, Salina P. Waddy, Kenneth Wiley, Andy Wilson, Margot Lisa Jing Yann, Zhiwei Zhang, Tianyue Zhou, Maya Petersen, Mark van der Laan   +19 more
wiley   +1 more source

Sensor-Uncertainty-Aware Conservative Robust Route Selection for Autonomous Robot Path Planning Under Occupancy-Grid Map Uncertainty. [PDF]

Sensors (Basel)
Allahloh AS, Ghaleb AM, Sarfraz M, Bouras A, Ali MAH, Al-Shayea A.   +5 more
europepmc   +1 more source

Unintended Pregnancies and Breastfeeding Studies during Central Nervous System Drug Development: How Are they Handled, Is There Room for Improvement?

Clinical Pharmacology &Therapeutics, EarlyView.
Pregnant and breastfeeding individuals are routinely excluded from clinical drug development, creating persistent evidence gaps in pharmacology, safety, and dosing. Despite mandatory contraception and pregnancy testing, unintended pregnancies occur, particularly during the development of central nervous system (CNS) medicines used by women of ...
Sam Schoenmakers, Charlotte Bakker, Alexandra Ganev, Florence Butlen‐Ducuing, Corinne S. de Vries   +4 more
wiley   +1 more source